Eyetech sales force to offer Pfizer's latanoprost

New York-Eyetech Pharmaceuticals Inc.'s sales force will help sell Pfizer Inc.'s once-daily latanoprost ophthalmic solution (Xalatan) to U.S. ophthalmologists.

Related Content:

Pharmacy

Comparable conscious sedation methods address individual patient needs

Investigators uncover health care disparities among US patients

Investigators zoom in on future of dry eye treatment